Emerging biological therapies in systemic lupus erythematosus. [electronic resource]
Producer: 20080124Description: 167-71 p. digitalISSN:- 1532-6535
- Antibodies, Monoclonal -- adverse effects
- Antigens, CD -- immunology
- Antigens, CD20 -- immunology
- Antigens, Differentiation -- immunology
- B-Cell Activating Factor -- antagonists & inhibitors
- Biological Therapy -- trends
- CD11a Antigen -- immunology
- CD40 Ligand -- antagonists & inhibitors
- CTLA-4 Antigen
- Humans
- Immunosuppressive Agents -- adverse effects
- Lupus Erythematosus, Systemic -- drug therapy
- Patient Selection
- Prognosis
- Sialic Acid Binding Ig-like Lectin 2 -- immunology
- Tumor Necrosis Factor-alpha -- antagonists & inhibitors
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.